Hui Yu

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma

Hui Yu, Xing Wang, Jiao Li et al. · Molecular Therapy — Oncolytics · 2021 · 46 citations · Full text

Medicine, Oncology, Pharmacology +15

Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p/IGF2 axis

Hui Yu, Luosha Zhao, Yang Zhao et al. · Vascular Pharmacology · 2020 · 35 citations

Life Sciences, Cell Biology, Molecular Biology +15

The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma

Xing Wang, Dedao Wang, Ning Ding et al. · Cancers · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma

Miaomiao Li, Hui Yu, Fei Qi et al. · Hematological Oncology · 2022 · 22 citations · Full text

Life Sciences, Immunology, Oncology +14

Injectable magnesium-bisphosphonate MOF-based bone adhesive prevents excessive fibrosis for osteoporotic fracture repair

Tianhua Xiao, Z.F. Gong, Dongming Duan et al. · Nature Communications · 2025 · 15 citations · Full text

Medicine, Bioengineering, Biomedical Engineering +17